million baht, decreased by 530 million baht compared to September 30, 2019 mainly due to the decrease of trade and other receivables. The total liabilities of the company were 849.65 million baht, decreased
Microsoft Word - MD&A.EN (Revised 3) (1) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon
, which increased by Baht 26.18 million or 27.87 %. The main reason was due to the company has derivatives products, which are Single Stock Futures Block Trade and Derivatives Warrants. 4. The Consolidated
been rendered by the Central Intellectual Property and International Trade Court, amounting 173 million Baht. However, the Company has a different view from the decision of the Court of First Instance in
Page 1 of 2 T.K.S. TECHNOLOGIES % GP Q1’20 Q1’19 As Reported (% to Sales) Total GP 21.7% 25.1% Company 19.4% 27.1% TBSP 22.6% 21.6% For the 1st quarter 2020, consolidated %GP reported at 21.7%, while
Baht 23 million from the balance at the ended of 31 December 2018. This were mainly because there was an increase in cash and cash equivalent the Company reserves to pay the dividend, and trade and other
product business and food business. 3.3 During the third quarter of 2018, the Company received the payment from trade receivables at the amount of Baht 270.48 million, which the Company had already
Sep. 2021 % 31 Dec. 2020 % Trade and other receivables 533.62 26% 468.82 23% Inventories 141.87 7% 125.97 6% Lease receivable 80.25 4% 83.74 4% Investment in associated company 223.35 11% 235.09 12
% Trade and other receivables 199.61 12% 120.51 9% Inventories 161.04 10% 119.88 8% Investment in associated company 319.19 20% 352.51 25% Property, plant and equipment 821.88 51% 712.57 51% Biological
-term loan from financial institutions. - Trade and other payables increased by Baht 85.22 million, because the Company investment equipment on the process of detail changing with contract. - Liabilities